Clinical Trial Update: The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder [NA]

View source ↗

Summary

A clinical trial evaluating agomelatine or fluoxentine on heart rate variability in patients with major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Agomelatine (agomelatine)
• Fluoxentine (Fluoxentine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Depressive Disorder, Major | NA | Status: WITHDRAWN